GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Inner Mongolia Furui Medical Science Co Ltd (SZSE:300049) » Definitions » Debt-to-Revenue

Inner Mongolia Furui Medical Science Co (SZSE:300049) Debt-to-Revenue : 0.06 (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Inner Mongolia Furui Medical Science Co Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Inner Mongolia Furui Medical Science Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥22 Mil. Inner Mongolia Furui Medical Science Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was ¥50 Mil. Inner Mongolia Furui Medical Science Co's annualized Revenue for the quarter that ended in Mar. 2025 was ¥1,322 Mil. Inner Mongolia Furui Medical Science Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2025 was 0.06.


Inner Mongolia Furui Medical Science Co Debt-to-Revenue Historical Data

The historical data trend for Inner Mongolia Furui Medical Science Co's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inner Mongolia Furui Medical Science Co Debt-to-Revenue Chart

Inner Mongolia Furui Medical Science Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.16 0.12 0.06 0.05 0.06

Inner Mongolia Furui Medical Science Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.05 0.05 0.05 0.06

Competitive Comparison of Inner Mongolia Furui Medical Science Co's Debt-to-Revenue

For the Biotechnology subindustry, Inner Mongolia Furui Medical Science Co's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inner Mongolia Furui Medical Science Co's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Inner Mongolia Furui Medical Science Co's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Inner Mongolia Furui Medical Science Co's Debt-to-Revenue falls into.


;
;

Inner Mongolia Furui Medical Science Co Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Inner Mongolia Furui Medical Science Co's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(21.176 + 55.242) / 1349.015
=0.06

Inner Mongolia Furui Medical Science Co's annualized Debt-to-Revenue for the quarter that ended in Mar. 2025 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(22.272 + 50.436) / 1321.608
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2025) Revenue data.


Inner Mongolia Furui Medical Science Co Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Inner Mongolia Furui Medical Science Co's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Inner Mongolia Furui Medical Science Co Business Description

Traded in Other Exchanges
N/A
Address
No. 103 Jiefang Road, Wulanchabu League, Inner Mongolia Autonomous Region, Jining, CHN, 012000
Inner Mongolia Furui Medical Science Co Ltd is a China based medical service platform company. It provides disease diagnosis, drug treatment and chronic disease management centered on the liver disease field. The product portfolio of the company includes tablets, capsules, and plaster. In addition, the company is also engaged in providing health-care services.
Executives
Di Xiu Juan Executives
Lin Xin Directors, Directors, and Executives
Wang Guan Yi Director
Wang Li Qun Supervisors
Wang Xin Hong Executives
Shuo Fei Directors, executives
Zhang Sui Yong Director
Zhao Xiao Dong Independent director
Yang Jin Bin Supervisors

Inner Mongolia Furui Medical Science Co Headlines

No Headlines